Your browser doesn't support javascript.
loading
Immunoproteasome Inhibitor-Doxorubicin Conjugates Target Multiple Myeloma Cells and Release Doxorubicin upon Low-Dose Photon Irradiation.
Maurits, Elmer; van de Graaff, Michel J; Maiorana, Santina; Wander, Dennis P A; Dekker, Patrick M; van der Zanden, Sabina Y; Florea, Bogdan I; Neefjes, Jacques J C; Overkleeft, Herman S; van Kasteren, Sander I.
Afiliación
  • Maurits E; Gorlaeus Laboratories, Leiden Institute of Chemistry, Leiden University, Leiden 2333 CC, The Netherlands.
  • van de Graaff MJ; Gorlaeus Laboratories, Leiden Institute of Chemistry, Leiden University, Leiden 2333 CC, The Netherlands.
  • Maiorana S; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98122 Messina, Italy.
  • Wander DPA; Gorlaeus Laboratories, Leiden Institute of Chemistry, Leiden University, Leiden 2333 CC, The Netherlands.
  • Dekker PM; Gorlaeus Laboratories, Leiden Institute of Chemistry, Leiden University, Leiden 2333 CC, The Netherlands.
  • van der Zanden SY; ONCODE Institute, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Florea BI; Gorlaeus Laboratories, Leiden Institute of Chemistry, Leiden University, Leiden 2333 CC, The Netherlands.
  • Neefjes JJC; ONCODE Institute, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Overkleeft HS; Gorlaeus Laboratories, Leiden Institute of Chemistry, Leiden University, Leiden 2333 CC, The Netherlands.
  • van Kasteren SI; Gorlaeus Laboratories, Leiden Institute of Chemistry, Leiden University, Leiden 2333 CC, The Netherlands.
J Am Chem Soc ; 142(16): 7250-7253, 2020 04 22.
Article en En | MEDLINE | ID: mdl-32275401

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Doxorrubicina / Óptica y Fotónica / Inhibidores de Proteasoma / Antibióticos Antineoplásicos / Mieloma Múltiple Límite: Humans Idioma: En Revista: J Am Chem Soc Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Doxorrubicina / Óptica y Fotónica / Inhibidores de Proteasoma / Antibióticos Antineoplásicos / Mieloma Múltiple Límite: Humans Idioma: En Revista: J Am Chem Soc Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos